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The paralogous human proteins UPF3A and UPF3B are involved in recognizing mRNAs 28 
targeted by nonsense-mediated mRNA decay (NMD). While UPF3B has been demonstrated 29 
to support NMD, contradicting reports describe UPF3A either as an NMD activator or inhibitor. 30 
Here, we present a comprehensive functional analysis of UPF3A and UPF3B in human cells 31 
using combinatory experimental approaches. Overexpression or knockout of UPF3A as well 32 
as knockout of UPF3B did not detectably change global NMD activity. In contrast, the co-33 
depletion of UPF3A and UPF3B resulted in a marked NMD inhibition and a transcriptome-wide 34 
upregulation of NMD substrates, demonstrating a functional redundancy between both NMD 35 
factors. Although current models assume that UPF3 bridges NMD-activating exon-junction 36 
complexes (EJC) to the NMD factor UPF2, UPF3B exhibited normal NMD activity in rescue 37 
experiments when UPF2 or EJC binding was impaired. Further rescue experiments revealed 38 
partially redundant functions of UPF3B domains in supporting NMD, involving both UPF2 and 39 
EJC interaction sites and the central region of UPF3. Collectively, UPF3A and UPF3B serve 40 
as fault-tolerant NMD activators in human cells. 41 
  42 
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Precisely regulated expression of correct gene products is indispensable for eukaryotic life. 44 
This is underlined by the existence of several quality control mechanisms for gene expression, 45 
one of which is the nonsense-mediated mRNA decay (NMD). NMD is primarily known for its 46 
ability to eliminate mature mRNAs that contain a premature termination codon (PTC). Thereby, 47 
NMD prevents the synthesis and accumulation of C-terminally truncated proteins, which may 48 
possess undesirable and potentially disease-causing properties (Frischmeyer & Dietz, 1999). 49 
Although the removal of PTC-containing mRNAs was initially considered the most important 50 
function of NMD, later studies showed that NMD plays an important role in the post-51 
transcriptional regulation of a substantial part of the transcriptome (He et al., 2003; Lelivelt & 52 
Culbertson, 1999; Mendell et al., 2004; Rehwinkel et al., 2005). The importance of the factors 53 
involved in NMD is underscored by the severe impact that mutations in components of this 54 
machinery have on development in metazoans, up to causing embryonic lethality in mammals 55 
(Hwang & Maquat, 2011; Li et al., 2015; McIlwain et al., 2010; Medghalchi et al., 2001; 56 
Metzstein & Krasnow, 2006; Weischenfeldt et al., 2008; Wittkopp et al., 2009). 57 
The final step of gene expression is the cytoplasmic translation of the mRNA by ribosomes. 58 
Previous studies suggested that prolonged ribosome stalling at a termination codon indicates 59 
improper translation termination and thereby triggers NMD (Amrani et al., 2004; Peixeiro et al., 60 
2012). This could be caused by a long 3’ untranslated region (UTR) that increases the distance 61 
between the stalled ribosome and the poly(A)-binding protein (PABPC1), which normally 62 
promotes proper translation termination (Amrani et al., 2004). Alternatively, NMD can also be 63 
activated by any PTC located more than 50-55 nt upstream of the 3’-most exon-exon junction. 64 
Transcripts with such a PTC may be transcribed from mutant genes with nonsense mutations 65 
but could also be generated by defective or alternative splicing (Kervestin & Jacobson, 2012). 66 
The aforementioned 50-55 nt boundary between NMD-activating and NMD-resistant PTCs is 67 
determined by the RNA-binding exon junction complex (EJC), which is deposited by the 68 
spliceosome 20-24 nt upstream of every spliced exon-exon junction (Le Hir et al., 2000). The 69 
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EJCs remain attached on the mature mRNA during export into the cytoplasm, where they are 70 
removed by translating ribosomes or the disassembly factor PYM1 (Dostie & Dreyfuss, 2002; 71 
Le Hir et al., 2000). If translation terminates prematurely due to the presence of a PTC, EJCs 72 
bound downstream of the PTC serve as a marker for the NMD machinery and the initial 73 
activation of NMD (Kim et al., 2001; Le Hir et al., 2001). 74 
Extensive research over many decades has resulted in a model for EJC-dependent NMD. 75 
According to this model, the central factor UPF1 is bound non-specifically to all present 76 
transcripts in the cell and is removed from the coding sequence by translating ribosomes (Hogg 77 
& Goff, 2010; Hurt et al., 2013; Kurosaki & Maquat, 2013; Zund et al., 2013). If translation 78 
terminates prematurely, UPF1 interacts with the stalled ribosome and serves as the anchoring 79 
point for the other NMD factors. The presence of a downstream EJC is detected by the 80 
interaction of UPF1 with UPF2, which in turn binds to UPF3. The latter can bind directly to the 81 
EJC, resulting in a bridged connection of UPF1 to the EJC (Chamieh et al., 2008; Kim et al., 82 
2001; Le Hir et al., 2001; Weng et al., 1996). This series of interactions marks the termination 83 
codon as premature and stimulates the phosphorylation of N- and C-terminal SQ motif-84 
containing regions of UPF1 by the kinase SMG1 (Yamashita et al., 2001). In its phosphorylated 85 
state UPF1 recruits the heterodimer SMG5-SMG7 and/or SMG6, which are responsible for 86 
both exoribonucleolytic and endoribonucleolytic degradation of the mRNA, respectively 87 
(Boehm et al., 2021; Chen & Shyu, 2003; Lejeune et al., 2003). The endonuclease SMG6 88 
cleaves the mRNA in close proximity to the PTC, resulting in two mRNA fragments (Eberle et 89 
al., 2009) of which the 3’ fragment is degraded by the 5’-to-3’ exoribonuclease XRN1 (Eberle 90 
et al., 2009; Huntzinger et al., 2008). 91 
The protein UPF3 plays an important role in the NMD pathway. As detailed above, its main 92 
function is believed to bridge the NMD machinery to the EJC providing a physical link between 93 
UPF2 and the EJC (Chamieh et al., 2008; Kashima et al., 2006; Lykke-Andersen et al., 2000; 94 
Serin et al., 2001). With its conserved RNA recognition motif (RRM) in the N-terminus, UPF3 95 
can interact with the C-terminal MIF4G (middle portion of eIF4G) domain of UPF2 (Kadlec et 96 
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al., 2004). The association with the EJC-binding site, formed by the core components EIF4A3, 97 
MAGOHB and RBM8A, is enabled by a C-terminal sequence referred to as EJC binding motif 98 
(EBM) (Buchwald et al., 2010; Gehring et al., 2003; Kim et al., 2001). 99 
In vertebrates two genes encode for two UPF3 paralogues: UPF3A and UPF3B, each of which 100 
expressing two different isoforms generated by alternative splicing (Lykke-Andersen et al., 101 
2000; Serin et al., 2001). Both human UPF3 proteins contain the same important domains, but 102 
differ in details regarding their interactions. According to previous studies, UPF3A and UPF3B 103 
are in constant competition for their binding partner UPF2. However, UPF3B binds tighter to 104 
UPF2 than UPF3A and therefore UPF3A gets destabilized, and its protein levels are barely 105 
detectable under normal conditions (Chan et al., 2009). 106 
Recently, UPF3B was reported to interact with the eukaryotic release factor 3 (eRF3) via the 107 
so far uncharacterized middle domain (amino acids (aa) 147-256) (Neu-Yilik et al., 2017). Due 108 
to this interaction and binding of the terminating ribosome, it can delay translation termination, 109 
which is known to define aberrant termination events and trigger NMD (Amrani et al., 2004; 110 
Neu-Yilik et al., 2017; Peixeiro et al., 2012). 111 
Due to the different molecular characteristics of the UPF3 paralogs, their exact role in NMD is 112 
a long-discussed topic. On the one hand, previous studies showed that UPF3A and UPF3B 113 
both trigger degradation of a reporter construct when tethered downstream of a termination 114 
codon. Notably, the efficiency of UPF3A to elicit NMD was weaker in comparison to UPF3B, 115 
which was attributed to a weaker interaction with the EJC (Kunz et al., 2006; Lykke-Andersen 116 
et al., 2000). This would suggest that, at least with respect to their NMD activity, UPF3A and 117 
UPF3B serve a similar, perhaps even redundant, function. This notion is supported by the 118 
observation that in patients with mutated UPF3B the amount of stabilized UPF3A inversely 119 
correlated with the severity of the patients’ clinical phenotypes (Nguyen et al., 2012). On the 120 
other hand, it was recently reported that loss of UPF3A results in increased transcript 121 
destabilization, and UFP3A overexpression in NMD inhibition (Shum et al., 2016). This would 122 
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rather indicate opposing functions of the two UPF3 paralogs with UPF3A being an antagonist 123 
of UPF3B and broadly acting as an NMD inhibitor. 124 
In this study, we resolved the controversy about the functions of UPF3A and UPF3B in the 125 
NMD pathway using different UPF3 overexpression and knockout (KO) HEK293 cell lines. We 126 
found that neither overexpression nor genomic KO of UPF3A resulted in substantial changes 127 
of NMD activity or global alterations of the transcriptome. In UPF3B KO cells UPF3A protein 128 
levels were upregulated, but NMD activity was maintained at almost normal level. In contrast, 129 
the co-depletion of both UPF3 paralogs resulted in a marked NMD inhibition and a global 130 
upregulation of PTC-containing transcripts. Moreover, rescue experiments revealed that UPF3 131 
proteins have additional functions besides bridging the EJC and the NMD machinery. Taken 132 
together, our data support a model of human NMD, in which UPF3A and UPF3B can replace 133 
each other and therefore perform redundant functions.   134 
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UPF3A overexpression or knockout does not affect NMD efficiency 136 
Prior work using different mammalian models and various experimental approaches reached 137 
different conclusions regarding the function of UPF3A in NMD (Fig 1A). Therefore, we set out 138 
to re-examine the role of UPF3A in human cells by specifically manipulating its expression 139 
levels. Under regular conditions UPF3A is barely present in cultured cells, presumably due to 140 
its lower binding affinity to the stabilizing interaction partner UPF2 compared to UPF3B, 141 
resulting in a rapid turnover of “free” UPF3A (Chan et al., 2009). We hypothesized that 142 
increasing the abundance of UPF3A should lead to the stabilization of NMD targets if UPF3A 143 
is an NMD inhibitor. To test this hypothesis, we generated Flp-In T-REx 293 (HEK 293) cells 144 
inducibly overexpressing FLAG-tagged wildtype UPF3A to high protein levels (Fig 1B). Global 145 
analysis of the transcriptome using RNA-seq (Fig EV1A and Datasets EV1-EV3) revealed, 146 
except for UPF3A itself, no significant differential gene expression (DGE), differential transcript 147 
usage (DTU) or alternative splicing (AS) events upon UPF3A overexpression compared to 148 
control conditions (Figs 1C and D). Using these RNA-seq data, we analyzed NMD targets that 149 
were previously described to be strongly upregulated in UPF3A overexpressing HeLa cells 150 
(Shum et al., 2016). The DGE analysis and visualization of the respective read coverage 151 
showed no substantial effects in our setup (Figs 1E and EV1B-E). Furthermore, quantification 152 
of differential transcript usage via IsoformSwitchAnalyzeR (Vitting-Seerup & Sandelin, 2019) 153 
could neither detect any differences in the global isoform fraction distribution, nor an 154 
accumulation of PTC-containing transcripts (Fig EV1F). Collectively, these analyses indicated 155 
that UPF3A overexpression in HEK 293 cells does not negatively affect gene expression in 156 
general or NMD in particular.  157 
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Figure 1 - UPF3A overexpression does not affect NMD
A Schematic representation of the bridge between UPF1 and the EJC during NMD. Binding of UPF3A instead of the stronger bound UPF3B is discussed to either activate or inhibit NMD.
B Western blot analyses after induced expression of FLAG-tagged UPF3A in WT HEK 293 cells. Tubulin serves as control.
C Fraction of expressed genes (genes with non-zero counts in DESeq2) were calculated which exhibit individual or combinations of differential gene expression (DGE), differential transcript usage (DTU) and/or 
alternative splicing (AS) events in WT cells overexpressing UPF3A using the respective computational analysis (cutoffs are indicated). AS and DTU events were collapsed on the gene level. For DGE, p-values were 
calculated by DESeq2 using a two-sided Wald test and corrected for multiple testing using the Benjamini-Hochberg method. For DTU, p-values were calculated by IsoformSwitchAnalyzeR (ISAR) using a DEXSeq-
based test and corrected for multiple testing using the Benjamini-Hochberg method. For AS, p-values were calculated by LeafCutter using an asymptotic Chi-squared distribution and corrected for multiple testing 
using the Benjamini-Hochberg method.
D Volcano plot showing the differential gene expression analyses from the RNA-Seq dataset of WT cells overexpressing UPF3A. The log2 fold change is plotted against the -log10 adjusted p-value (adj. p-value). P-
values were calculated by DESeq2 using a two-sided Wald test and corrected for multiple testing using the Benjamini-Hochberg method. OE = overexpression.
E Read coverage of SMG5 from WT HEK 293 RNA-seq data with or without induced UPF3A overexpression shown as Integrative Genomics Viewer (IGV) snapshot. Differential gene expression (from DESeq2) is 
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Next, we approached the question of UPF3A function in the opposite way by generating 159 
UPF3A knockout (KO) HEK 293 cell lines. Using CRISPR-Cas9 genome editing we isolated 160 
three clones that lacked the UPF3A-specific band on the Western blot even after 161 
downregulation of UPF3B (Fig 2A). Two clones (14 and 20) were characterized in detail.  162 
In both cell lines, the UPF3A genomic locus contained insertions and/or deletions causing 163 
frame-shifts and eventually PTCs (Figs EV2A-C). To gain a first impression of the NMD activity 164 
in the UPF3A KO cells, the transcript levels of three known exemplary endogenous NMD 165 
targets, RSRC2, SRSF2 and ZFAS1 were determined by qPCR (Boehm et al., 2021; Lykke-166 
Andersen et al., 2014; Sureau et al., 2001). WT HEK 293 cells treated with SMG6 and SMG7 167 
siRNAs were used as a positive control for severe NMD inhibition (Fig 2B)(Boehm et al., 2021). 168 
While the absence of UPF3A did not result in abundance changes of SRSF2 and RSRC2 169 
NMD-sensitive isoforms (mean log2FC between -0.44 and 0.79), ZFAS1 mRNA levels were 170 
slightly decreased in the UPF3A KO cells compared to WT cells (mean log2FC -0.42 and -1.01 171 
for UPF3A KO clones 14 and 20, respectively; Fig 2B). However, this effect was not rescued 172 
by the (over)expression of transgenic UPF3A, indicating that it is not caused by the lack of 173 
UPF3A but rather represents random variations in gene expression or clonal effects (Figs 174 
EV2D-E). To get a complete overview of the effects of the UPF3A KO, we performed RNA-seq 175 
of two UPF3A KO cell lines with or without an additional UPF3B knockdown (KD; Fig EV2F 176 
and Datasets EV1-EV3). Initially, we focused on the UPF3A KO cell lines without KDs, for 177 
which the global transcriptome analysis revealed that about 4-9 % of the expressed genes are 178 
altered (Figs 2C-E). The observation that in the absence of UPF3A more genes were 179 
downregulated than upregulated (879 vs. 676) could be an indicator for UPF3A NMD inhibiting 180 
properties (Fig 2F). However, the majority of genes with altered expression were clone specific 181 
and only 110 genes showed downregulation in both UPF3A KO cell lines (Fig 2F). Investigation 182 
of selected targets that were significantly up- or downregulated in both clones revealed that 183 
the changes were not rescued after UPF3A overexpression, suggesting that they are UPF3A-184 
independent (Figs EV2D-E). Another indication that UPF3A depletion does not generally affect 185 
NMD efficiency came from the DTU analysis.  186 
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Figure 2 - UPF3A KOs show light NMD-independent transcriptome alterations
A Western blot analysis of WT and UPF3A KO cells (clones 4, 14 and 20) with the indicated siRNA treatments. UPF3A and UPF3B protein levels were detected, Tubulin serves as control.
B Quantitative RT-PCR of the indicated cell lines treated with the indicated siRNAs for 2 or 6 days. For RSRC2 and SRSF2 the ratio of NMD isoform to canonical isoform was calculated. ZFAS1 expression was 
normalized to C1orf43 reference. Data points and means are plotted as Log2 fold change (n=3 for RSRC2 and SRSF2, n=4 for ZFAS1).
C Fraction of expressed genes (genes with non-zero counts in DESeq2) were calculated which exhibit individual or combinations of differential gene expression (DGE), differential transcript usage (DTU) and/or 
alternative splicing (AS) events in the indicated conditions using the respective computational analysis (cutoffs are indicated). AS and DTU events were collapsed on the gene level. For DGE, p-values were calculated 
by DESeq2 using a two-sided Wald test and corrected for multiple testing using the Benjamini-Hochberg method. For DTU, p-values were calculated by IsoformSwitchAnalyzeR using a DEXSeq-based test and 
corrected for multiple testing using the Benjamini-Hochberg method. For AS, p-values were calculated by LeafCutter using an asymptotic Chi-squared distribution and corrected for multiple testing using the 
Benjamini-Hochberg method.
D,E Volcano plots showing the differential gene expression analyses from the indicated RNA-Seq datasets (D UPF3A KO clone 14, E UPF3A KO clone 20). The log2 fold change is plotted against the -log10 adjusted 
p-value (padj). P-values were calculated by DESeq2 using a two-sided Wald test and corrected for multiple testing using the Benjamini-Hochberg method
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Although clone 14 showed a minor downregulation of PTC-containing transcripts, which could 188 
indicate more active NMD, this effect was not reproducible in the second clone (Fig EV2G). In 189 
view of and in combination with the results shown in Fig 1, this strongly suggests that neither 190 
the overexpression nor the depletion of UPF3A substantially alters (negatively or positively) 191 
the efficiency of NMD. In conclusion, our data argue against a role for UPF3A as a general 192 
negative NMD regulator in human cell lines. 193 
NMD is functional in the absence of UPF3B 194 
Next, we investigated the RNA-seq data of UPF3B knockdowns in the UPF3A KO cells 195 
(Datasets EV1-EV3). We observed that this combination resulted in more transcriptome 196 
alterations and an increase of PTC-containing isoforms (Figs 2B-C, EV2H and I). Although the 197 
UPF3B KD alone could be in principle responsible for this effect, the results could also be an 198 
indicator for redundant functions of the two UPF3 paralogs. To explore this hypothesis, we 199 
decided to generate UPF3B KO cell lines. Western blot analysis demonstrated that a UPF3B 200 
KD is less efficient in reducing the produced protein than the UPF3B KO in the two clones 201 
designated as 90 and 91 (Figs 3A and EV3A-B). In addition, we observed a strong upregulation 202 
of UPF3A after depletion (KO) or reduction (KD) of UPF3B, as described before (Chan et al., 203 
2009). In the absence of UPF3B no changes in the expression of the respective NMD-sensitive 204 
isoforms of the NMD-targets RSRC2 and SRSF2 was observed (Fig 3B). This indicates that 205 
either UPF3B is not essential for NMD or that another protein is able to compensate for its 206 
loss. The most obvious candidate for this function is its own paralog UPF3A, which was also 207 
suggested previously to functionally replace UPF3B in NMD. Indeed, knocking down UPF3A 208 
in the UPF3B KO cells resulted in the increase of NMD-sensitive RSRC2 and SRSF2 isoforms 209 
(Fig 3B). Of note, the combination of the UPF3B KO with UPF3A KD showed stronger effects 210 
than the previously analyzed UPF3A KO plus UPF3B KD. This is probably caused by the lower 211 
KD efficiency of the UPF3B siRNAs which can be observed by comparing the respective 212 
protein levels (Fig 2A vs. Fig 3A). We suspect that the remaining UPF3B levels after siRNA-213 
mediated UPF3B KD still support NMD.  214 
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Figure 3 - Loss of UPF3B does not affect NMD efficiency, only in combination with KD of UPF3A
A Western blot analysis of WT and UPF3B KO cells (clones 90 and 91) combined with the indicated knockdowns. UPF3A and UPF3B (AK-141) protein levels were detected, Tubulin serves as control.
B Quantitative RT-PCR of the indicated cell lines with the indicated knockdowns. For RSRC2 and SRSF2 the ratio of NMD isoform to canonical isoform was calculated. Data points and means are plotted as Log2 fold 
change (n=3).
C Fraction of expressed genes (genes with non-zero counts in DESeq2) were calculated which exhibit individual or combinations of differential gene expression (DGE), differential transcript usage (DTU) and/or 
alternative splicing (AS) events in the indicated conditions using the respective computational analysis (cutoffs are indicated). AS and DTU events were collapsed on the gene level. For DGE, p-values were calculated 
by DESeq2 using a two-sided Wald test and corrected for multiple testing using the Benjamini-Hochberg method. For DTU, p-values were calculated by IsoformSwitchAnalyzeR using a DEXSeq-based test and 
corrected for multiple testing using the Benjamini-Hochberg method. For AS, p-values were calculated by LeafCutter using an asymptotic Chi-squared distribution and corrected for multiple testing using the 
Benjamini-Hochberg method.
D,E Volcano plots showing the differential transcript usage (via IsoformSwitchAnalyzeR) in various RNA-Seq data. Isoforms containing GENCODE (release 33) annotated PTC (red, TRUE), regular stop codons 
(blue, FALSE) or having no annotated open reading frame (grey, NA) are indicated. The change in isoform fraction (dIF) is plotted against the -log10 adjusted p-value (adj.p-value). Density plots show the distribution 
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To gain more transcriptome-wide information, we performed RNA-seq of the UPF3B KO clone 216 
90, with and without UPF3A siRNA treatment (Fig EV3C and Datasets EV1-EV3). The global 217 
effects detected in the RNA-seq data correlated well with the NMD inhibition seen for single 218 
targets (Figs 3C and EV3D-G). Analysis of the differential transcript usage revealed an 219 
upregulation of transcripts annotated with a PTC only in the UPF3B KO cells with additionally 220 
downregulated UPF3A (Figs 3D and E). This increase of NMD-sensitive transcripts could not 221 
be observed in the plain UPF3B KO cells with UPF3A naturally upregulated. All together this 222 
data strongly suggested at least partial redundancy of UPF3A and UPF3B, since KO of only 223 
one paralog was irrelevant for NMD functionality. Furthermore, we were able to show that also 224 
in the absence of UPF3B an overexpression of UPF3A has no negative effects on NMD 225 
efficiency, supporting the previous conclusion of UPF3A not being a negative NMD regulator 226 
(Figs EV3H and I).  227 
Stronger NMD impairment in UPF3A-UPF3B double KO cells 228 
Considering that UPF3A and UPF3B seemingly carry out redundant functions, we decided to 229 
create a cell line completely lacking both paralogs and aimed to generate UPF3A-UPF3B 230 
double KO cells (UPF3 dKO). These cells should show stronger effects than the combination 231 
of a KO and a KD, since residual amounts of protein were typically still detected after siRNA 232 
treatment. Using the UPF3B-KO clone 90 as parental cell line, two potential UPF3 dKO clones 233 
1 and 2 were generated (Fig 4A), which differed in the guide RNAs used to target exon 1 of 234 
UPF3A. We confirmed that both cell lines contained frame shift-inducing insertions/deletions 235 
at the respective positions in the UPF3A gene (Figs 4B, EV4A and B). We first explored by 236 
qPCR how strongly the dKO affected NMD (Fig 4C). For all three tested genes, the expression 237 
of the NMD-sensitive isoform was further increased compared to the previously used 238 
combination of UPF3B KO with additional UPF3A KD. Of note, the NMD inhibitory effect 239 
observed in the dKOs became more pronounced after UPF3B siRNA transfection, suggesting 240 
that low levels of residual UPF3B protein were still present in the dKO cells (Fig EV4C).   241 
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Figure 4 - KO of both UPF3 paralogs results in strongly impaired NMD
A Western blot analysis of WT, UPF3B KO and UPF3A-UPF3B doubleKO cells (clones 1 and 2). UPF3A and UPF3B protein levels were detected, Tubulin serves as control.
B Schematic depiction of the insertion/deletion in the UPF3A open reading frame resulting in the additional UPF3A KO in the UPF3B KO clone 90 generating UPF3 dKO clones.
C Quantitative RT-PCR of the indicated samples with the indicated KDs. For RSRC2 and SRSF2 the ratio of NMD isoform to canonical isoform was calculated. ZFAS1 expression was normalized to C1orf43 
reference. Data points and means are plotted as Log2 fold change (n=3).
D Schematic overview of the globin reporter constructs and their functional elements.
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The expression levels of endogenous NMD substrates could be influenced by transcription 243 
rates or other indirect effects, which could lead to over- or underestimating NMD inhibition. 244 
Therefore, we investigated the NMD efficiency in the dKO cells using the well-established β-245 
globin NMD reporter. To this end, we stably integrated β-globin WT or PTC39 constructs in 246 
WT and UPF3 dKO cells (Fig 4D). These reporters also contained XRN1-resistant sequences 247 
(xrRNAs) in their 3’ UTRs, which allowed us to analyze not only the degradation of the full-248 
length reporter mRNA but also to quantify decay intermediates (called xrFrag) (Boehm et al., 249 
2016; Voigt et al., 2019). The PTC39 mRNA was efficiently degraded and a strong xrFrag 250 
observed in WT cells, whereas in dKO cells the PTC39 reporter accumulated to high levels 251 
(72% compared to the WT mRNA), which was accompanied by a decrease in the amount of 252 
xrFrag. (Fig 4E, lane 2 vs. lane 4). In line with the previous observations, this result indicated 253 
a strong decrease of NMD activity upon the KO of both UPF3 paralogs using a robust NMD 254 
reporter pair expressed independently of endogenous NMD substrates, supporting the 255 
functional redundancy of UPF3A and UPF3B in NMD. 256 
To establish transcriptome-wide insights into UPF3A and UPF3B function, we carried out RNA-257 
seq for both dKO clones, which was combined with and without UPF3B KD treatment to 258 
eliminate as many of the potentially present remaining UPF3B proteins (Fig EV5A and 259 
Datasets EV1-EV3). Differential gene expression analysis showed that nearly three times as 260 
many genes were upregulated than downregulated in both dKO cells (Figs 5A and EV5B). This 261 
is consistent with the redundant role of UPF3B and UPF3A as supporting NMD factors. The 262 
considerable overlap between both clones also suggests that we identified high-confidence 263 
UPF3 targets. Furthermore, 890 of these gene were also significantly upregulated in previously 264 
generated SMG7 KO plus SMG6 KD data (Fig EV5C, ref data: (Boehm et al., 2021)) indicating 265 
that these are universal NMD-targets and not specific to a certain branch of the NMD pathway. 266 
In addition to DGE, subsets of the expressed genes showed changes in alternative splicing 267 
or/and differential transcript usage (Fig 5B). In total, 14-16 % of the global transcriptome 268 
showed single or combined changes (DGE, DTU and/or AS) and up to 20% when the cells 269 
were treated with an additional UPF3B KD.  270 
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Figure 5 - RNA-seq reveals strong global upregulation of NMD-sensitive targets upon UPF3 dKO in HEK293 cells 
A nVenn Diagram showing the overlap of up- or downregulated genes in the UPF3 dKO cell lines 1 and 2. Log2 fold change <-1 (downregulated) or >1 (upregulated) and adjusted p-value (padj) < 0.05. DGE = 
Differential Gene Expression.
B Fraction of expressed genes (genes with non-zero counts in DESeq2) were calculated which exhibit individual or combinations of differential gene expression (DGE), differential transcript usage (DTU) and/or 
alternative splicing (AS) events in the indicated conditions using the respective computational analysis (cutoffs are indicated). AS and DTU events were collapsed on the gene level. For DGE, p-values were calculated 
by DESeq2 using a two-sided Wald test and corrected for multiple testing using the Benjamini-Hochberg method. For DTU, p-values were calculated by IsoformSwitchAnalyzeR using a DEXSeq-based test and 
corrected for multiple testing using the Benjamini-Hochberg method. For AS, p-values were calculated by LeafCutter using an asymptotic Chi-squared distribution and corrected for multiple testing using the 
Benjamini-Hochberg method.
C Volcano plots showing the differential transcript usage (via IsoformSwitchAnalyzeR) in various RNA-Seq data. Isoforms containing GENCODE (release 33) annotated PTC (red, TRUE), regular stop codons (blue, 
FALSE) or having no annotated open reading frame (grey, NA) are indicated. The change in isoform fraction (dIF) is plotted against the -log10 adjusted p-value (adj.p-value). Density plots show the distribution of 
filtered isoforms in respect to the dIF, cutoffs were |dIF| > 0.1 and adj.p-value < 0.05. P-values were calculated by IsoformSwitchAnalyzeR using a DEXSeq-based test and corrected for multiple testing using the 
Benjamini-Hochberg method.
D Read coverage of SRSF2 from the indicated RNA-seq sample data with or without UPF3A siRNA treatment shown as Integrative Genomics Viewer (IGV) snapshot. The canonical and NMD-sensitive isoforms are 

































DESeq2: |log2FC| > 1 & adj. p-value < 0.05 
 ISAR: |dIF| > 0.1 & adj. p-value < 0.05 
 leafcutter: |dPSI| > 0.1 & adj. p-value < 0.05
cell line
siRNA

















-1.0 -0.5 0.0 0.5 1.0





















-1.0 -0.5 0.0 0.5 1.0
















-1.0 -0.5 0.0 0.5 1.0



















-1.0 -0.5 0.0 0.5 1.0










PTC NA FALSE TRUE
A
16 
.CC-BY-NC 4.0 International licensemade available under a
(which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is 
The copyright holder for this preprintthis version posted July 13, 2021. ; https://doi.org/10.1101/2021.07.07.451444doi: bioRxiv preprint 
17 
 
In agreement with NMD inhibition in the dKOs, we saw that many transcripts containing a PTC 272 
were up-regulated, while the corresponding transcripts without a PTC were down-regulated. 273 
(Figs 5C and EV5D). Under these conditions, the IGV snapshot of the NMD-target SRSF2 274 
showed NMD-inducing exon inclusion and 3’ UTR splicing events, which were not visible in 275 
combined UPF3B KO/UPF3A KD cells (Fig 5D). Collectively, the RNA-seq data support the 276 
previously observed strong NMD inhibition in response to the complete absence of both UPF3 277 
paralogs and hence their proposed redundancy. 278 
UPF3A supports NMD independent of a bridge function 279 
Next, we aimed to analyze whether the severe effects in the dKOs are at least partly due to 280 
the loss of a protein-protein interaction bridge between UPF2 and the EJC, while the presence 281 
of UPF3A in the UPF3B KOs preserved this function ensuring NMD functionality. Therefore, 282 
we expressed FLAG-tagged UPF2 in WT, UPF3B KO and UPF3A-UPF3B dKO cells and 283 
analyzed the UPF2 interactome using mass spectrometry (Dataset EV4). Consistent with the 284 
previously described interaction partners, we found many NMD factors as well as EJC proteins 285 
in the UPF2 interactome in WT cells (Fig 6A). Contrary to our expectation, the three EJC core 286 
components (EIF4A3, RBM8A, MAGOHB) barely co-precipitated with UPF2 in the absence of 287 
UPF3B (compared to control: log2 FC = 0.58, 0.63 and 0.74, respectively; Fig 6B) and were 288 
therefore strongly decreased in comparison to the WT cells (Fig EV6A). Hence, the UPF2-289 
bound UPF3A was unable to establish a stable interaction with the EJC. Surprisingly, in the 290 
UPF3B KO cells the EJC-associated CASC3 still showed relatively high levels of co-291 
precipitation (log2 FC = 4.42), which therefore appears to be independent of the interaction 292 
with the other EJC components. In the dKOs all interactions with EJC proteins including 293 
CASC3 were completely lost (Figs 6C and EV6B). The latter was also observed in a 294 
comparable approach employing stable isotope labeling with amino acids in cell culture 295 
(SILAC) to analyze the UPF2 interactome in the WT and dKO cells (Dataset EV5). All EJC 296 
core components that were highly co-precipitated in WT cells were lost in the absence of both 297 
UPF3 paralogs (Figs EV6C-E).  298 
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Figure 6 - Interaction of UPF3A and UPF3B with the EJC is dispensable to elicit NMD
A-C Volcano plots of label free mass spectrometry-based analysis of the interaction partners of UPF2 in WT cells treated with control siRNAs and the UPF3B KO clone 90 and dKO clone 1 both treated with siRNAs 
targeting UPF3B (n = 4 biologically independent samples). (A) FLAG-UPF2 in WT against FLAG-GST control in WT cells, (B) UPF2 in 3B KO cells against FLAG control in WT cells, (C) UPF2 in dKO cells against 
FLAG control in WT cells. Points labeled in purple indicate NMD factors; points labeled in turquoise indicate EJC components. Cut offs: Log2 fold change ≥ 0
D Schematic representation of the UPF3B protein domains and the respective functions. Below are the mutated rescue constructs and their respective abstract placeholders.
E Western blot analysis of WT and UPF3B KO clone 90 with Luciferase and UPF3A KDs respectively. Monitored expression of the FLAG-tagged UPF3B rescue construct shown in (D). Rescue construct protein levels 
were detected with anti-FLAG and anti-UPF3B (AK-141) antibodies. Tubulin serves as control.
F Quantitative RT-PCR of the samples from (E). For RSRC2 and SRSF2 the ratio of NMD isoform to canonical isoform was calculated. ZFAS1 expression was normalized to C1orf43 reference. Data points and means 
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Partially redundant functions of UPF3B domains are required for NMD 300 
With regard to the surprising observation that UPF3A apparently elicits NMD without 301 
interacting with the EJC, we aimed to investigate the molecular features required by UPF3 to 302 
support NMD via rescue experiments. In principle, the UPF3 dKO cells represent an ideal 303 
system for this approach. However, apart from the residual amounts of UPF3B that were still 304 
expressed, we noticed that the UFP3 dKOs were able to upregulate the expression of a 305 
shortened UPF3B variant after long-term cultivation. 306 
Since this phenomenon did not occur in the single UPF3B KOs, we generated stable UPF3B 307 
KO cell lines expressing various inducible UPF3B constructs with individual or combined 308 
binding site mutations (Figs 6D and E and EV6F). Transfection of these cells with UPF3A 309 
siRNAs resulted in the robust depletion of UPF3 for the analysis of the rescue activities of 310 
individual UPF3B variants. Considering the established role of UPF3B as a bridge between 311 
UPF2 and the EJC, which we validated in the mass spec analysis, it was surprising to see that 312 
disruption of either of these interactions did not affect UPF3B’s rescue capacity (Fig 6F, lane 313 
3 vs. lanes 4 and 5). This is partially consistent with the observed functional NMD in UPF3B 314 
KOs, despite the apparent inability of UPF3A to form a bridge between UPF2 and the EJC 315 
(Figs 3C and 6B). However, mutating both UPF3B binding sites (disrupting UPF2 and EJC 316 
binding) largely inactivated the NMD-related function of UPF3B.  317 
It was recently reported that EJC-bound or free UPF3B can interact with the eukaryotic release 318 
factor 3 (eRF3) via the so far uncharacterized middle domain (aa 147-256) (Neu-Yilik et al., 319 
2017). With this interaction and binding of the terminating ribosome, UPF3B can delay 320 
translation termination, which defines aberrant termination events and triggers NMD (Amrani 321 
et al., 2004; Neu-Yilik et al., 2017; Peixeiro et al., 2012). To investigate the impact of this 322 
interaction on NMD, we created UPF3B variants lacking that specific middle domain or 323 
combined the deletion with the previously used interaction mutations (Fig 6D and E). We 324 
observed a similar pattern as the UPF3B mutants examined in the previous experiment: when 325 
only the middle domain was deleted, UPF3B was able to rescue NMD comparable to the WT 326 
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protein (Fig 6F lane 7). In combination with a mutation in the UPF2- or the EJC binding site its 327 
function in NMD was severely impaired (lanes 8 and 9). This suggests that if the classic bridge 328 
formation is inhibited by removing either of the interaction sites, UPF3B relied on the function 329 
carried out by the uncharacterized middle domain.  330 
As further support for the NMD promoting effect of UPF3A on NMD, we performed a rescue 331 
experiment in the above used UPF3B KO UPF3A KD cells (Figs 7A and B). Expression of the 332 
siRNA insensitive UPF3A construct did not only restore NMD functionality, it was even more 333 
efficient than the UPF3B construct (Fig 7C lane 3 vs. lane 5), underlining our previous 334 
statement: UPF3A supports and elicits NMD comparably to its paralog UPF3B. 335 
Also comparable to UPF3B, UPF3A has a second naturally occurring isoform but instead of 336 
skipping exon 8 (like UPF3B) it excludes its fourth exon. This isoform is transcribed in 337 
approximately one third of the cases (Fig EV6G) in WT HEK 293 cells but cannot be detected 338 
on protein levels. We were interested, whether this isoform was as potent to elicit NMD as the 339 
full-length construct. Expression of the exon 4 UPF3A deletion construct in the UPF3 depleted 340 
cells showed no rescue (Fig 7C lane 4). Hence, exon 4 must encode for an essential region 341 
required for the bridge-independent function of UPF3A. 342 
In view of these observations and the close proximity of exon 4 (124-157) to the middle domain 343 
(147-256), we decided to investigate which effect the deletion of the homologous exon 4 in the 344 
paralog UPF3B has. The UPF3B Δe4 construct behaved like the corresponding UPF3A 345 
construct and showed no NMD rescue activity (lane 6). However, the expression of the N-346 
terminus of UPF3B was able to restore NMD comparably to the WT protein (lane 7). This is 347 
consistent with all our previous findings, since the first 279 amino acids contain the UPF2 348 
binding site as well as the middle domain, which was shown to be sufficient to elicit NMD (Fig 349 
6F lane 5). Due to the fact that the C-terminus contains only one interaction site and lacks exon 350 
4, its incapability to rescue NMD is in line with our previous experiments. Overall, our results 351 
identify exon 4 of UPF3 as a previously unnoticed region that is essential for its function in 352 
NMD.  353 
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Figure 7 - WT UPF3A can rescue NMD in full extent. Deletion on exon 4 disrupts functionality in both paralogs.
A Schematic representation of the UPF3A and UPF3B protein domains. Below are the respective mutated rescue constructs.
B Western blot analysis of WT and UPF3B KO clone 90 with Luciferase and UPF3A KDs respectively. Monitored expression of the FLAG-tagged UPF3A and UPF3B rescue construct shown in (A). Rescue construct 
protein levels were detected with anti-FLAG, anti-UPF3A and anti-UPF3B (AK-141) antibodies. Tubulin serves as control.
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Methodological advances - be it improved analytics or novel experimental approaches - can 356 
help to find new answers to old biological problems. Equipped with powerful new molecular 357 
biology methods, we set out to answer the question which functions the two UPF3 paralogs 358 
carry out in human cells. Since the initial description of mammalian UPF3A and UPF3B (Lykke-359 
Andersen et al., 2000; Serin et al., 2001), many researchers have been engaged in determining 360 
the function and work distribution of these two proteins in NMD. It became clear relatively early 361 
that UPF3A and UPF3B can both interact with UPF2 as well as the EJC and activate NMD 362 
(Gehring et al., 2003; Kim et al., 2001; Lykke-Andersen et al., 2000; Serin et al., 2001). But 363 
significant differences in these interactions and the amounts of UPF3A and UPF3B proteins 364 
were also found, leading to the hypothesis that UPF3B is the central player and UPF3A more 365 
its backup (Chan et al., 2009; Kunz et al., 2006). The investigations were further intensified 366 
upon the discovery that mutations in the human UPF3B gene lead to various forms of mental 367 
disorder (Nguyen et al., 2014). Disease severity seems to be dictated by the amount of UPF3A 368 
present, suggesting again a compensatory mechanism and redundant functions of UPF3B and 369 
UPF3A (Nguyen et al., 2012).  370 
Later, it was reported that in mouse cells UPF3B is an NMD activator and UPF3A is an NMD 371 
inhibitor (Shum et al., 2016). Accordingly, removal of UPF3A resulted in enhanced NMD, 372 
whereas removal of UPF3B inhibited NMD. Recently, another function of UPF3B was 373 
discovered, namely that it is involved in different phases of translation termination (Neu-Yilik 374 
et al., 2017). UPF3B not only interacts with release factors, but also slows down translation 375 
termination and promotes dissociation of post-termination ribosomal complexes. Whether 376 
these functions of UPF3B in translation termination are related to its function in NMD has not 377 
been clarified to date. 378 
Although our results cannot fully answer this last question, we have more or less definite 379 
answers for the functions of the two proteins UPF3A and UPF3B in NMD. All our data support 380 
the notion that the presence of UPF3B or UPF3A is sufficient to maintain NMD activity in 381 
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human cells. First, we see at most a weak inhibition of NMD in our HEK 293 UPF3B KO cells. 382 
However, this does not necessarily mean that all cell types display full NMD activity after a KO 383 
of UPF3B. Instead, it is conceivable that HEK 293 cells are just particularly robust against the 384 
UPF3B depletion or particularly efficient at the compensatory upregulation of UPF3A. Likewise, 385 
we see no NMD inhibition in cells overexpressing UPF3A or NMD “boosting” in UPF3A KO 386 
cells. Only when we deplete in UPF3A or UPF3B KO cell lines the respective other protein by 387 
RNAi or genomic KO, NMD efficiency substantially decreases. It should be noted that the 388 
effects of a KO on NMD activity are typically stronger than those of a KD, which is consistent 389 
with our earlier observations (Boehm et al., 2021; Gerbracht et al., 2020). Although our data 390 
clearly argue against an NMD-inhibitory function of UPF3A, experimental differences exist 391 
between our work and the work describing the NMD inhibition by UPF3A. While we have used 392 
human HEK293 cells, the results of Shum et al. were obtained in P19 mouse cells and mouse 393 
embryonic fibroblasts (MEFs). Both, the different organisms and the different types of cells 394 
could have influenced the results. Interestingly, in a parallel manuscript, Yi et al. find that 395 
mouse UPF3A can rescue NMD in human HCT116 UPF3A-UPF3B dKO cells (Yi et al., 2021). 396 
Although these results were obtained in a heterologous context, mouse UPF3A does not 397 
appear to be a general NMD inhibitor. 398 
The different KO cells that we have generated in the course of this project enabled us to 399 
conduct experiments that went beyond investigating UPF3-dependent NMD substrates in 400 
human cells. Specifically, we were able to study the composition of NMD complexes without 401 
UPF3B or both UPF3 proteins and to carry out rescue experiments with different UPF3A and 402 
UPF3B protein variants. Not entirely unexpected, we observed that in the absence of UPF3A 403 
and UPF3B, the interaction between UPF2 and the EJC is lost. This bridging by UPF3 between 404 
UPF2-containing NMD complexes and the EJC was previously considered to be essential for 405 
NMD. However, two observations argue against UPF3 being mainly a bridging protein. First, 406 
UPF3B mutants that cannot interact with either the EJC or UPF2 fully rescue NMD. Only when 407 
both interaction sites were mutated, UPF3 lost its NMD function. This indicates that the 408 
interaction with one of the two interaction partners is sufficient to maintain NMD. Second, we 409 
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observed that not only in UPF3 double-KO cells, but also in UPF3B KO cells, the bridge 410 
between UPF2 and the EJC was lost. Although quite surprising at first glance, this is in good 411 
agreement with previous results showing that the interaction between the EJC and UPF3A is 412 
substantially weaker than that between the EJC and UPF3B (Kunz et al., 2006). Indeed, earlier 413 
structural data also argue against a bridging function of UPF3. In the cryo-EM structure of an 414 
EJC-UPF3-UPF2-UPF1 complex, UPF1 did not face towards a possible terminating ribosome 415 
in the 5' direction, but instead in 3' direction (Melero et al., 2012). Therefore, one could 416 
conclude that the interactions between all these proteins do not take place at a single time 417 
point during NMD. 418 
This raises the question of what UPF3 function is essential for NMD, if it is not its bridging 419 
function? Our rescue experiments showed that the middle domain of UPF3B cooperates with 420 
the UPF2- and the EJC interaction sites, i.e., its deletion in combination with one other mutation 421 
inactivates UPF3B. The middle domain has been described to mediate the interaction of 422 
UPF3B with release factor 3 (RF3), but this interaction has not been demonstrated for UPF3A 423 
(Neu-Yilik et al., 2017). So, if UPF3A cannot interact with RF3 and also binds weaker to the 424 
EJC as noted above, it should be functionally inactive. However, we see no obvious difference 425 
between UPF3B and UPF3A in the rescue experiments. These and other observations can, in 426 
our view, only be explained with more complex models, which must also consider non-linear 427 
relationships and potential auxiliary functions of certain regions of UPF3 (Fig 8). 428 
Since the interactions of UPF3 are essential only in combination with each other, we propose 429 
that UPF3A and UPF3B exert multiple functions at different time points of NMD and in 430 
association with different complexes. We only consider here the previously described 431 
interactions of UPF3 with UPF2, the EJC and the release factor 3 (Fig 8B). While it was 432 
previously described that UPF3B interacts better than UPF3A with UPF2 (Chan et al., 2009), 433 
we find both proteins in the FLAG-UPF2 IP. The amount of UPF3A does not seem to increase 434 
when UPF3B is depleted, which could be due to the overexpression of UPF2 in our 435 
experimental system. The interaction of UPF3 and UPF2 is also conserved in yeast and is thus  436 
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Figure 8 - Model for potentially independent functions of UPF3 in NMD.
A Both UPF3 paralogs UPF3A and UPF3B can elicit NMD and trigger mRNA degradation. We propose a new model where UPF3B exerts multiple functions at different timepoints during NMD.
B Schematic overview of UPF3B domain structure and the postulated functions. Conservation between UPF3A (UniProt ID: Q9H1J1-1) and UPF3B (UniProt ID: Q9BZI7-2) proteins as calculated via Clustal Omega 
and Jalview is shown.
C Via the RRM-like domain in the N-terminus of the protein it interacts with UPF2, which might be important for the assembly of an NMD-inducing complex. The middle domain was ascribed to be responsible for the 
interaction with eRF3 and potential translation termination delay. The interaction with the EJC via the EBM could stabilize the complex by preventing its interaction with the disassembly factor PYM1. Only if two out of 
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likely to have functional significance. However, a UPF3B mutant in which binding to UPF2 was 438 
inactivated rescues NMD better than the UPF3B WT.  439 
The interaction of the middle domain of UPF3B with RF3 has only recently been described 440 
(Neu-Yilik et al., 2017). Again, we find that removing only the middle domain does not 441 
substantially inhibit NMD. In combination with an inactivation of the UPF2 binding, the deletion 442 
of the middle domain leads to a complete inhibition of the NMD in the rescue assay. This could 443 
also happen when exon 4 of UPF3B or UPF3A is removed, which is located at the junction 444 
between the UPF2 binding domain and the middle domain. Therefore, UPF3A Δexon4 would 445 
be a naturally occurring, NMD-inactive variant of the UPF3 proteins. 446 
How might the different regions and domains communicate with each other and regulate the 447 
function of UPF3 in NMD? The function of the middle domain in relation to NMD has not yet 448 
been investigated. It is conceivable that UPF3B plays a minor role in translation termination 449 
and that the events that trigger NMD can also occur without the middle domain - potentially 450 
with a delay (Figure 8c). Therefore, the deletion of the middle domain could be tolerated in 451 
isolation but would become fatal in combination with other mutations that impair additional 452 
functions. With regard to the EBM, we propose that its binding stabilizes the EJC, for example 453 
by preventing the interaction of the EJC with PYM1 (Fig 8C). PYM1 is a known EJC 454 
disassembly factor and binds to the EJC at a surface area that overlaps with the EBM binding 455 
site (Bono et al., 2004; Buchwald et al., 2010; Gehring et al., 2009). We suggest that in cells 456 
rescued with the ΔEBM mutant EJCs are more readily dissociated from the mRNA in the 457 
cytoplasm. The concomitant loss of UPF3B’s termination function (Δmiddle domain, ΔEBM) 458 
would have a dramatic effect on NMD efficiency, because NMD would be initiated too slowly. 459 
Likewise, the interaction of UPF3 with UPF2 might be important for the assembly of an NMD-460 
inducing complex (Fig 8C) that needs to be timed with translation termination and that leads 461 
to NMD activation only in the presence of the EJC. Although these suggestions may not 462 
accurately reflect the molecular events during NMD, they illustrate possible functions of the 463 
domains of UPF3, particularly in relation to their NMD-inactive combinations (Fig 8). Overall, 464 
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our observations fit well with a "synthetic lethal" model in which inactivation of any two domains 465 
together disrupts UPF3 activity. 466 
One factor whose function needs to be examined in more detail in the context of UPF3 is 467 
CASC3. Our mass spectrometry analysis shows that CASC3 immunoprecipitates very well 468 
with UPF2 in wildtype cells. CASC3 still partially precipitates with UPF2 in UPF3B KO cells, 469 
although the interaction of the other EJC factors is reduced to background levels. In previous 470 
work, we observed that UPF3B interacts less well with the EJC when CASC3 is knocked out 471 
(Gerbracht et al., 2020). This indicates that an interaction between CASC3 and the UPF3 472 
proteins exists that is not well understood so far. What kind of interaction this is and what 473 
function it has will be interesting to address in future experiments. 474 
Our own work and the work of Yi et al. have re-examined the functions of the human UPF3 475 
paralogues UPF3A and UPF3B (Yi et al., 2021). Together, the studies confirmed some 476 
previous findings and disconfirmed others, thereby successfully (re-)defining the role of UPF3 477 
proteins in human cells. A few questions remain unanswered and need to be addressed in the 478 
future, for example how exactly the middle domain supports NMD. As described above, our 479 
results have implications for the understanding of the NMD mechanism, as they are 480 
incompatible with, and thus exclude, certain models of NMD. In addition, they may also help 481 
to better understand the link between UPF3B and intellectual disability and which domains of 482 
UPF3A modulate the severity of the disease and may therefore be potential targets for therapy.   483 
 484 
  485 
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Materials and Methods 486 
Cell Culture 487 
Flp-In-T-REx-293 (human, female, embryonic kidney, epithelial; Thermo Fisher Scientific, 488 
RRID:CVCL_U427) cells were cultured in high-glucose, GlutaMAX DMEM (Gibco) 489 
supplemented with 9% fetal bovine serum (Gibco) and 1x Penicillin Streptomycin (Gibco). The 490 
cells were cultivated at 37°C and 5% CO2 in a humidified incubator. The generation of 491 
knockout and stable cell lines is described below and all cell lines are summarized in Dataset 492 
EV6. 493 
siRNA-mediated knockdowns 494 
For reverse transfection the cells were seeded at a density of 2.5x105 cells per well. The 495 
transfection solution contained 2.5 µl Lipofectamine RNAiMAX and 60 pmol of the respective 496 
siRNAs. For the UPF3A and UPF3B knockdowns 30 pmol of both belonging siRNAs were 497 
used. In preparation for mass spectrometry, 2.5x106 were reverse transfected in 10 cm plates 498 
using 6.25 µl Lipofectamine RNAiMAX and 150-200 pmol siRNA (or half of it for each of the 499 
two siRNAs for UPF3A or UPF3B). All siRNAs used in this study are listed in Dataset EV6. 500 
Plasmid transfection 501 
For each stable transfection 2.5-3.0x105 cells were seeded one day prior transfection in 6-502 
wells. To express the N-terminally FLAG-tagged protein constructs and reporter mRNAs for 503 
northern blotting, they were stably integrated using the PiggyBac (PB) Transposon system with 504 
the cumate-inducible PB-CuO-MCS-BGH-EF1-CymR-Puro vector. This vector was modified 505 
from the original vector (PB-CuO-MCS-IRES-GFP-EF1α-CymR-Puro (System Biosciences)) 506 
by replacing the IRES-GFP cassette with a BGH polyA signal. Per well 1.0 μg of the respective 507 
PB vector and 0.8 μg PB Transposase were transfected using a calcium phosphate-based 508 
system with BES buffered saline (BBS). Additionally, 0.5 μg of pCI-maxGFP was transfected 509 
as a visual feedback for transfection efficiency. 48 h later, the cells were pooled in 10 cm plates 510 
and selected for positive cells by incubation in media containing 2 μg/ml puromycin for a week. 511 
.CC-BY-NC 4.0 International licensemade available under a
(which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is 
The copyright holder for this preprintthis version posted July 13, 2021. ; https://doi.org/10.1101/2021.07.07.451444doi: bioRxiv preprint 
29 
 
To induce expression of the constructs, 30 μg/ml cumate was added and the cells were 512 
harvested after 72h for continuing experiments. 513 
The mRNA reporter constructs β-globin WT and β-globin PTC are available on Addgene (IDs 514 
108375-108376). All vectors used in this study are listed in Dataset EV6. 515 
Generation of knockout cells using CRISPR-Cas9 516 
The knockouts were performed using the Alt-R CRISPR-Cas9 system (Integrated DNA 517 
Technologies) and reverse transfection of a Cas9:guideRNA ribonucleoprotein complex using 518 
Lipofectamine RNAiMAX (Thermo Fisher Scientific) according to the manufacturer’s protocol. 519 
The crRNA sequence (Integrated DNA Technologies) to target UPF3B was 520 
/AltR1/rArGrArUrArArGrCrArGrGrArUrCrGrCrArArCrArGrUrUrUrUrArGrArGrCrUrArUrGrCrU/521 
AltR2/. For UPF3A the crRNA sequences were /AltR1/rCrCrGrCrArArCrCrGrGrArGrGrArC 522 
rGrArArGrUrGrUrUrUrUrArGrArGrCrUrArUrGrCrU/AltR2/ for clone 1 and /AltR1/rGrCrGrGr 523 
UrGrGrArArCrUrGrCrArCrUrUrCrUrArGrUrUrUrUrArGrArGrCrUrArUrGrCrU/AltR2/ for clone 524 
2. Reverse transfection was performed on 1.5×105 cells per crRNA in 12-well plates. 48 h after 525 
transfection the cells were trypsinized, counted and seeded at a mean density of a single cell 526 
per well in 96-well plates. Cell colonies originating from a single clone were then screened via 527 
Western blot and genome editing of UPF3A and UPF3B was analyzed on the genomic level 528 
via DNA extraction and Sanger sequencing. Alterations on the transcript level were analyzed 529 
via RNA extraction followed by reverse transcription and Sanger sequencing. 530 
DNA and RNA extraction 531 
Genomic DNA extraction using QuickExtract DNA Extraction Solution (Lucigen) was 532 
performed according to manufacturer’s instruction. For RNA extraction cells were harvested 533 
with 1 ml RNAsolv reagent (Omega Bio-Tek) per 6 well and RNA was isolated according to 534 
manufacturer’s instruction, with the following changes: instead of 200 μl chloroform, 150 μl 1-535 
Bromo-3-chloropropane (Sigma-Aldrich) was added to the RNAsolv. Additionally, in the last 536 
step the RNA pellet was dissolved in 20 μl RNase-free water by incubating for 10 min on a 537 
shaking 65 °C heat block. 538 
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Western blotting 539 
SDS-polyacrylamide gel electrophoresis and immunoblot analysis were performed using 540 
protein samples harvested with RIPA buffer (50 mM Tris/HCl pH 8.0, 0.1% SDS, 150 mM NaCl, 541 
1% IGEPAL, 0.5% deoxycholate) or samples eluted from Anti-FLAG M2 magnetic beads. For 542 
protein quantification, the Pierce Detergent Compatible Bradford Assay Reagent (Thermo 543 
Fisher Scientific) was used. All antibodies used in this study are listed in Dataset EV6. 544 
Detection was performed with Western Lightning Plus-ECL (PerkinElmer) or ECL Select 545 
Western Blotting Detection Reagent (Amersham) and the Vilber Fusion FX6 Edge imaging 546 
system (Vilber Lourmat).  547 
Semi-quantitative and quantitative reverse transcriptase (RT)-PCR 548 
Reverse transcription was performed with 1-4 µg of total RNA in a 20 µl reaction volume with 549 
10 µM VNN-(dT)20 primer and the GoScript Reverse Transcriptase (Promega). For the semi-550 
quantitative end-point PCRs the MyTaq Red Mix (Bioline) was used. Quantitative RT-PCRs 551 
were performed with the GoTaq qPCR Master Mix (Promega), 2% of cDNA per reaction, and 552 
the CFX96 Touch Real-Time PCR Detection System (Bio-Rad). Each biological replicate was 553 
repeated in technical triplicates and the average Ct (threshold cycle) value was measured. 554 
When isoform switches were measured, values for NMD sensitive isoforms were normalized 555 
to the canonical isoforms to calculate ΔCt. For differentially expressed genes, the 556 
housekeeping gene C1orf43 values were subtracted from the target value to receive the ΔCt. 557 
To calculate the mean log2 fold changes three biologically independent experiments were 558 
used. The log2 fold changes are visualized as single data points and mean. All primers used 559 
in this study are listed in Dataset EV6. 560 
RNA-sequencing and computational analyses 561 
Four different RNA-seq experiments were performed: 1) unaltered Flp-In T-REx 293 wild type 562 
(WT) cells and WT cells overexpressing the UPF3A WT construct via the PB-Transposase 563 
system. 2) Flp-In T-REx 293 wild type (WT) cells transfected with Luciferase siRNA and the 564 
UPF3A KO clones 14 and 20 treated with either Luciferase or UPF3B siRNAs. 3) The control 565 
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Flp-In T-REx 293 wild type (WT) cells with a Luciferase KD and the UPF3B KO clone 90 566 
transfected with Luciferase or UPF3A siRNAs. 4) WT cells transfected with Luciferase siRNA 567 
and the two UPF3 double KO cell lines 1 and 2 transfected with either Luciferase or UPF3B 568 
siRNAs. RNA was purified using peqGOLD TriFast (VWR Peqlab; for UPF3B KO samples) or 569 
the Direct-zol RNA MiniPrep kit including the recommended DNase I treatment (Zymo 570 
Research; all other samples) according to manufacturer’s instructions. Three biological 571 
replicates were analyzed for each sample. 572 
The Lexogen SIRV Set3 Spike-In Control Mix (SKU: 051.0x; for UPF3B KO samples) or ERCC 573 
RNA Spike-In Mix (for all other samples) that provides a set of external RNA controls was 574 
added to the total RNA to enable performance assessment. The Spike-Ins were used for 575 
quality control purposes, but not used for the final analysis of DGE, DTU or AS.  576 
Using the Illumina TruSeq Stranded Total RNA kit library preparation was accomplished. This 577 
includes removing ribosomal RNA via biotinylated target-specific oligos combined with Ribo-578 
Zero gold rRNA removal beads from 1 μg total RNA input. Cytoplasmic and mitochondrial 579 
rRNA gets depleted by the Ribo-Zero Human/Mouse/Rat kit. After a purification step, the RNA 580 
gets cleaved and fragmented. These fragments are then reverse transcribed into first strand 581 
cDNA using reverse transcriptase and random primers. In the next step, using DNA 582 
Polymerase I and RNase H second strand cDNA synthesis is performed. The resulting cDNA 583 
fragments then have the extension of a single’A’ base and adapter ligation. To create the final 584 
cDNA library the products are purified and enriched with PCR. Next library validation and 585 
quantification (Agilent tape station) are performed, followed by pooling of equimolar amounts 586 
of library. The pool itself was then quantified using the Peqlab KAPA Library Quantification Kit 587 
and the Applied Biosystems 7900HT Sequence Detection System and sequenced on an 588 
Illumina HiSeq4000 sequencing instrument with an PE75 protocol (UPF3B KO samples) or 589 
Illumina NovaSeq6000 sequencing instrument with an PE100 protocol (all other samples). 590 
Reads were aligned against the human genome (version 38, GENCODE release 33 transcript 591 
annotations (Frankish et al., 2019) supplemented with SIRVomeERCCome annotations from 592 
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Lexogen; obtained from https://www.lexogen.com/sirvs/download/) using the STAR read 593 
aligner (version 2.7.3a) (Dobin et al., 2013). Transcript abundance estimates were computed 594 
with Salmon (version 1.3.0) (Patro et al., 2017) with a decoy-aware transcriptome. After the 595 
import of transcript abundances, differential gene expression analysis was performed with the 596 
DESeq2(Love et al., 2014) R package (version 1.28.1) with the significance thresholds 597 
|log2FoldChange|> 1 and adjusted p-value (padj) < 0.05. Differential splicing was detected with 598 
LeafCutter (version 0.2.9) (Li et al., 2018) with the significance thresholds |deltapsi| > 0.1 and 599 
adjusted p-value (p.adjust) < 0.05. Differential transcript usage was computed with 600 
IsoformSwitchAnalyzeR (version 1.10.0) and the DEXSeq method (Anders et al., 2012; Ritchie 601 
et al., 2015; Robinson & Oshlack, 2010; Soneson et al., 2015; Vitting-Seerup & Sandelin, 2017, 602 
2019). Significance thresholds were |dIF| > 0.1 and adjusted p-value (isoform_switch_q_value) 603 
< 0.05.  604 
PTC status of transcript isoforms with annotated open reading frame was determined by 605 
IsoformSwitchAnalyzeR using the 50 nucleotide (nt) rule of NMD (Huber et al., 2015; Vitting-606 
Seerup et al., 2014; Vitting-Seerup & Sandelin, 2017; Weischenfeldt et al., 2012). Isoforms 607 
with no annotated open reading frame in GENCODE were designated “NA” in the PTC 608 
analysis. 609 
All scripts and parameters for the RNA-Seq analysis are available at GitHub 610 
[https://github.com/boehmv/UPF3]. Overlaps of data sets were represented via nVenn(Perez-611 
Silva et al., 2018) or the ComplexHeatmap package (version 2.6.2)(Gu et al., 2016). Integrative 612 
Genomics Viewer (IGV) (version 2.8.12)(Robinson et al., 2011) snapshots were generated 613 
from mapped reads (BAM files) converted to binary tiled data (tdf), using Alfred(Rausch et al., 614 
2019) with resolution set to 1 and IGVtools.  615 
SILAC and mass spectrometry 616 
HEK293 WT cells and the UPF3 dKO clone 2 expressing either FLAG-tagged GST or UPF2 617 
were labeled by culturing them for at least 5 passages in DMEM for SILAC medium (Thermo 618 
Fisher Scientific) supplemented with 9% FBS (Silantes), 1% Penicillin-Streptomycin and the 619 
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labeled amino acids Lysin and Arginine at final concentrations of 0.798 mmol/L and 0.393 620 
mmol/L, respectively. The three conditions were “light” (unlabeled Lys/ Arg), “medium” (Lys4/ 621 
Arg6) and “heavy” (Lys8/ Arg10). Unlabeled proline was added in all conditions to prevent 622 
enzymatic Arginine-to-Proline conversion. 623 
Experimental setup for SILAC with FLAG-tagged UPF2 624 
Expression of FLAG-GST and FLAG-UPF2 was induced for 72 h with 1x cumate. The cells 625 
lysed in 250 – 400 μl Buffer E with 1 μg/ml RNase and sonicated using the Bandelin Sonopuls 626 
mini20 with 15x 1s pulses at 50% amplitude with a 2.5 mm tip. Protein concentrations were 627 
measured using the Bradford assay and protein samples containing 1.6-1.7 mg/ml total protein 628 
were diluted. 600 μl of these samples were incubated with 30 μl Anti-FLAG M2 magnetic beads 629 
(Sigma) for 2 h on an overhead shaker at 4 °C. The beads were then washed three times for 630 
5 min with mild EJC-Buffer before eluting twice with 22 μl of a 200 μg/ml dilution of FLAG-631 
peptides (Sigma) in 1x TBS for 10 min at RT and 200 rpm each elution step. Another elution 632 
with 1x SDS loading buffer was performed to analyze pull down efficiency via Western blot. 633 
The FLAG-peptide eluates were then mixed as followed: 7 μl of both light conditions, 14 μl 634 
medium and 14 μl heavy. 1 volume of SP3 (10% SDS in PBS) was added and the samples 635 
were reduced with 5 mM DTT and alkylated with 40 mM CAA.  636 
Tryptic protein digestion was achieved by following a modified version of the single pot solid 637 
phase-enhanced sample preparation (SP3) (Hughes et al., 2014). In brief, paramagnetic Sera-638 
Mag speed beads (Thermo Fisher Scientific) were added to the reduced and alkylated protein 639 
samples and then mixed 1:1 with 100% acetonitrile (ACN). Protein-beads-complexes form 640 
during the 8 min incubation step, followed by capture using an in-house build magnetic rack. 641 
After two washing steps with 70% EtOH, the samples were washed once with 100% ACN. 642 
Then they were air-dried, resuspended in 5 μl 50 mM Triethylamonium bicarbonate 643 
supplemented with trypsin and LysC in an enzyme:substrate ratio of 1:50 and incubated for 16 644 
h at 37°C. The next day the beads were again resuspended in 200 μl ACN and after 8 min 645 
incubation placed on the magnetic rack. Tryptic peptides were washed with 100% ACN and 646 
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air-dried before dissolved in 4% DMSO and transfer into 96-well PCR tubes. The last step was 647 
the acidification with 1 μl of 10% formic acid, then the samples were ready for mass spec 648 
analysis. 649 
Proteomics analysis was performed by the proteomics core facility at CECAD via data-650 
dependent acquisition using an Easy nLC1200 ultra high-performance liquid chromatography 651 
(UHPLC) system connected via nano electrospray ionization to a Q Exactive Plus instrument 652 
(all Thermo Scientific) running in DDA Top10 mode. Based on their hydrophobicity the tryptic 653 
peptides were separated using a chromatographic gradient of 60 min with a binary system of 654 
buffer A (0.1% formic acid) and buffer B (80% ACN, 0.1% formic acid) with a total flow of 250 655 
nl/min. For the separation in-house made analytical columns (length: 50 cm, inner diameter: 656 
75 μm) containing 2.7 μm C18 Poroshell EC120 beads (Agilent) that were heated to 50 °C in 657 
a column oven (Sonation) were used. Over a time period of 41 min Buffer B was linearly 658 
increased from 3% to 27% and then more rapidly up to 50% in 8 min. Finally, buffer B was 659 
increased to 95% within 1 min followed by 10 min at 95% to wash the analytical column. Full 660 
MS spectra (300-1,750 m/z) were accomplished with a resolution of 70,000, a maximum 661 
injection time of 20 ms and an AGC target of 3e6. In each full MS spectrum, the top 10 most 662 
abundant ions were selected for HCD fragmentation (NCE:27) with a quadrupole isolation 663 
width of 1.8 m/z and 10 s dynamic exclusion. The MS/MS spectra were then measured with a 664 
35,000 resolution, an injection time of maximum 110 ms and an AGC target of 5e5. 665 
The MS RAW files were then analyzed with MaxQuant suite (version 1.5.3.8) on standard 666 
settings with the before mentioned SILAC labels (Cox & Mann, 2008). By matching against the 667 
human UniProt database the peptides were then identified using the Andromeda scoring 668 
algorithm (Cox et al., 2011). Carbamidomethylation of cysteine was defined as a fixed 669 
modification, while methionine oxidation and N-terminal acetylation were variable 670 
modifications. The digestion protein was Trypsin/P. A false discovery rate (FDR) < 0.01 was 671 
used to identify peptide-spectrum matches and to quantify the proteins. Data processing and 672 
statistical analysis was performed in the Perseus software (version 1.6.1.1) (Tyanova et al., 673 
.CC-BY-NC 4.0 International licensemade available under a
(which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is 
The copyright holder for this preprintthis version posted July 13, 2021. ; https://doi.org/10.1101/2021.07.07.451444doi: bioRxiv preprint 
35 
 
2016). Using the One-sample t-test the significantly changed proteins were identified (H0 = 0, 674 
fudge factor S0 = 0.2). Visualization was performed with RStudio (version 1.2.5033). 675 
Label-free quantitative mass spectrometry 676 
Twenty-four hours before expression of the FLAG-tagged constructs, the HEK 293 WT cells 677 
were treated with Luciferase siRNA and the UPF3B KO clone 90 and UPF3 dKO clone 1 cells 678 
were treated with siRNAs targeting residual UPF3B. The expression of either FLAG-GST or 679 
FLAG-UPF2 in WT cells and FLAG-UPF2 in the clones 90 and 1 was induced for 48 h with 1x. 680 
Lysis and sample preparation were performed as described above. MS analysis was 681 
performed as described above with a slightly adjusted gradient as followed: 3 – 30% B in 41 682 
min, 30 – 50% B in 8 min, 50-95% B in 1 min, followed by 10 min washing at 95%. LFQ values 683 
were calculated using the MaxLFQ algorithm (Cox et al., 2014) in MaxQuant. Significantly 684 
changed proteins were identified by two-sample t-testing (fudge factor S0 = 0.2). 685 
Northern Blotting 686 
The cells were harvested in RNAsolv reagent and total RNA extraction was performed as 687 
described above. 3.0 µg total RNA were resolved on a 1% agarose/0.4 M formaldehyde gel 688 
using the tricine/triethanolamine buffer system (Mansour & Pestov, 2013). Next a transfer on 689 
a nylon membrane (Roth) in 10x SSC followed. The blot was incubated overnight at 65°C in 690 
Church buffer containing [α-32P]-GTP body-labeled RNA-probes for mRNA reporter detection 691 
(Voigt et al., 2019). Ethidium bromide stained 28S and 18S rRNA served as loading controls. 692 
RNA signal detected with the Typhoon FLA 7000 (GE Healthcare) was quantified in a semi-693 
automated manner using the ImageQuant TL 1D software with a rolling-ball background 694 
correction. EtBr-stained rRNA bands were quantified with the Image Lab 6.0.1 software (Bio-695 
Rad). Signal intensities were normalized to the internal control (rRNA) before calculation of 696 
mean values. The control condition was set to unity (TPI WT for reporter assays), quantification 697 
results are shown as data points and mean. 698 
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Protein conservation 699 
UPF3A (UniProt ID: Q9H1J1-1) and UPF3B (UniProt ID: Q9BZI7-2) protein sequences were 700 
aligned using Clustal Omega (https://www.ebi.ac.uk/Tools/msa/clustalo/) (Goujon et al., 2010; 701 
Sievers et al., 2011), viewed using Jalview (Waterhouse et al., 2009), the conservation score 702 
extracted and used for visualization. 703 
Data Presentation 704 
Quantifications and calculations for other experiments were performed - if not indicated 705 
otherwise - with Microsoft Excel (version 1808) or R (version 4.0.4) and all plots were 706 
generated using IGV (version 2.8.12), GraphPad Prism 5, ggplot2 (version 3.3.3) or 707 
ComplexHeatmap (version 2.6.2) (Gu et al., 2016).  708 
Data Availability 709 
The datasets and computer code produced in this study are available in the following 710 
databases: 711 
• RNA-Seq data for UPF3B KO samples: ArrayExpress E-MTAB-10711 712 
(https://www.ebi.ac.uk/arrayexpress/experiments/E-MTAB-10711)  713 
• RNA-Seq data for UPF3 dKO samples: ArrayExpress E-MTAB-10716 714 
(https://www.ebi.ac.uk/arrayexpress/experiments/E-MTAB-10716) 715 
• RNA-Seq data for UPF3A KO/OE samples: ArrayExpress E-MTAB-10718 716 
(https://www.ebi.ac.uk/arrayexpress/experiments/E-MTAB-10718) 717 
• Mass spectrometry proteomics data: PRIDE PXD027120 718 
(https://www.ebi.ac.uk/pride/archive/projects/PXD027120) 719 
• Codes used in this study: GitHub (https://github.com/boehmv/UPF3) 720 
All relevant data supporting the key findings of this study are available within the article and its 721 
Expanded View files or from the corresponding author upon reasonable request.   722 
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